Showing results (361-370 of 492) with videos related to

Sort By:
Pageof 50
The Journal of Trauma|February 5, 1999
Circulating postinjury neutrophils are primed for the release of proinflammatory cytokinesG Zallen, E E Moore, J L Johnson, et al.
American Journal of Medical Genetics|December 18, 2001
Molybdopterin synthase mutations in a mild case of molybdenum cofactor deficiencyJ L Johnson, K E Coyne, K V Rajagopalan, et al.
Molecular Vision|May 20, 2009
Comparative genomic mapping of uncharacterized canine retinal ESTs to identify novel candidate genes for hereditary retinal disordersB Zangerl, J L Johnson, J Pillardy, et al.
The Journal of Biological Chemistry|May 23, 1998
Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47PHOX on serine 303 or 304O Inanami, J L Johnson, J K McAdara, et al.
Molecular and Cellular Biology|November 2, 2001
The Hsp70-Ydj1 molecular chaperone represses the activity of the heme activator protein Hap1 in the absence of hemeT Hon, H C Lee, A Hach, et al.
Journal of Gerontological Nursing|March 28, 2002
How accurate are chronic wound assessments using interactive video technology?S E Gardner, R A Frantz, J K Specht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsivenessM S Czuczman, J P Leonard, S Jung, et al.
Journal of Surgical Oncology|January 1, 1976
Neuraminidase immunotherapy: serum potentiation of lymphocyte cytotoxicity related to immunoglobulin levelsE E Miller, A S Brown, J L Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group BD R Budman, G R Petroni, J L Johnson, et al.
Biochemistry|November 26, 1999
Enhanced efficiency of ATP hydrolysis during nitrogenase catalysis utilizing reductants that form the all-ferrous redox state of the Fe proteinJ A Erickson, A C Nyborg, J L Johnson, et al.
Pageof 50